A minimally invasive surgical option engineered for mild-to-moderate male stress urinary incontinence. A specialized synthetic mesh support framework is precisely positioned beneath the bulbous urethra, providing static compression and elevation to secure the natural closure mechanics against exertion.

Clinical Indication

This procedure is highly indicated for patients experiencing structural anomalies, severe localized scar tissue, or functional blockages that fail to resolve with initial conservative therapeutic adjustments.

Surgical Objective

The principal objective is the complete restoration of physiological form, functional urinary path independence, or mechanical integrity, maximizing long-term outcomes while minimizing systemic downtime.

The Male Transobturator Urethral Sling is a minimally invasive surgical option designed for men with mild to moderate stress urinary incontinence (typically 1 to 3 pads per day) following prostate surgery. Unlike the Artificial Urinary Sphincter, which requires manual pump activation to void, the male sling works completely passively: a synthetic polypropylene mesh hammock gently compresses and elevates the bulbous urethra, reinforcing the damaged sphincter mechanism without any moving mechanical parts.

Clinical Indications & Patient Selection

Indicated for post-prostatectomy men with mild to moderate stress leakage who have intact voluntary external sphincter function on flexible cystoscopy.

Mild to Moderate SUI (1–3 pads/day): Leakage occurring during coughing, laughing, golf, or heavy physical exertion.

Absence of Pelvic Radiation: Best outcomes occur in non-radiated tissue beds; radiation significantly increases mesh erosion and failure risks.

Normal Bladder Capacity & Compliance: Normal detrusor pressures without severe urgency or uninhibited overactive contractions.

Surgical Technique & Procedural Nuance

Performed through a single small perineal incision with transobturator needle passage.

Bulbous Urethra Exposure: The bulbospongiosus muscle is exposed and mobilized in the midline.

Transobturator Mesh Passage: Mesh arms are passed through the obturator foramen on either side using helical trocars.

Dynamic Retrograde Leak Point Tensioning: The sling is tensioned against the bulbous urethra while retrograde leak point pressure is measured, establishing adequate resistance without creating obstruction.

Postoperative Pathway & Recovery Timeline

Performed as a same-day ambulatory outpatient procedure taking less than 45 minutes.

Catheter Duration: Foley catheter is removed the morning after surgery or prior to discharge.

Immediate Continence: Because there is no deactivation period, patients experience improved continence immediately upon catheter removal.

Activity Restrictions: Crucial to avoid squatting, heavy lifting (>15 lbs), and straddle seating for 6 weeks to allow mesh tissue incorporation.

Outcomes, Durability & Clinical Evidence

Highly successful in carefully selected non-radiated patients desiring a discreet, non-mechanical solution.

Improvement: Most well-selected men become dry or need only a single security pad.

Zero Device Maintenance: No mechanical components that can fail, leak, or require cycling.

The Male Transobturator Urethral Sling is a minimally invasive surgical option designed for men with mild to moderate stress urinary incontinence (typically 1 to 3 pads per day) following prostate surgery. Unlike the Artificial Urinary Sphincter, which requires manual pump activation to void, the male sling works completely passively: a synthetic polypropylene mesh hammock gently compresses and elevates the bulbous urethra, reinforcing the damaged sphincter mechanism without any moving mechanical parts.

Clinical Indications & Patient Selection

Indicated for post-prostatectomy men with mild to moderate stress leakage who have intact voluntary external sphincter function on flexible cystoscopy.

Mild to Moderate SUI (1–3 pads/day): Leakage occurring during coughing, laughing, golf, or heavy physical exertion.

Absence of Pelvic Radiation: Best outcomes occur in non-radiated tissue beds; radiation significantly increases mesh erosion and failure risks.

Normal Bladder Capacity & Compliance: Normal detrusor pressures without severe urgency or uninhibited overactive contractions.

Surgical Technique & Procedural Nuance

Performed through a single small perineal incision with transobturator needle passage.

Bulbous Urethra Exposure: The bulbospongiosus muscle is exposed and mobilized in the midline.

Transobturator Mesh Passage: Mesh arms are passed through the obturator foramen on either side using helical trocars.

Dynamic Retrograde Leak Point Tensioning: The sling is tensioned against the bulbous urethra while retrograde leak point pressure is measured, establishing adequate resistance without creating obstruction.

Postoperative Pathway & Recovery Timeline

Performed as a same-day ambulatory outpatient procedure taking less than 45 minutes.

Catheter Duration: Foley catheter is removed the morning after surgery or prior to discharge.

Immediate Continence: Because there is no deactivation period, patients experience improved continence immediately upon catheter removal.

Activity Restrictions: Crucial to avoid squatting, heavy lifting (>15 lbs), and straddle seating for 6 weeks to allow mesh tissue incorporation.

Outcomes, Durability & Clinical Evidence

Highly successful in carefully selected non-radiated patients desiring a discreet, non-mechanical solution.

Improvement: Most well-selected men become dry or need only a single security pad.

Zero Device Maintenance: No mechanical components that can fail, leak, or require cycling.

Related Conditions & Patient Recovery Protocols

Clinical Subspecialty Hub: Urinary Incontinence & Voiding Restoration →

Underlying Clinical Condition: Male Urinary Incontinence →